Menu Search
Equities

Cryofocus Medtech (Shanghai) Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
6922:HKG.HS

Cryofocus Medtech (Shanghai) Co Ltd

Actions
  • Price (HKD)6.03
  • Today's Change0.11 / 1.86%
  • Shares traded200.00
  • 1 Year change-4.29%
  • Beta--
Data delayed at least 15 minutes, as of Feb 16 2026 01:32 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Cryofocus Medtech (Shanghai) Co Ltd is a China-based company mainly engaged in the research, development, and production of medical device. The Company mainly focuses on the field of minimallyinvasive interventional cryotherapy. The Company's product portfolio mainly focuses on two therapeutic areas, including vascular interventional therapy for the treatment of atrial fibrillation, hypertension and other cardiovascular diseases, and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases. The Company's products include AF Cryoablation System, COPD Cryospray System, Bladder Cryoablation System, Atrial Fibrillation Pulsed Field Ablation (PFA) System, and others.

  • Revenue in HKD (TTM)96.45m
  • Net income in HKD-86.09m
  • Incorporated2013
  • Employees180.00
  • Location
    Cryofocus Medtech (Shanghai) Co LtdLane 3399Kangxin Highway, Pudong New AreaSHANGHAI 201318ChinaCHN
  • Phone+86 2 120977850
  • Websitehttps://www.cryofocus.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.